IRVINE, Calif., Jan. 19 /PRNewswire/ -- Medical Care Corporation (MCC), a provider of technology based diagnostic tools that enable professionals to detect early-stage memory loss, announced its expansion into Japan. Licensing agreements have been finalized with three Japanese healthcare companies, Toyaku Corporation, Saint-Care Corporation, and Millennia Corporation. The rights to commercialize MCC’s proprietary technology allow these firms to deliver a comprehensive range of dementia-care services, including: prevention, early detection, accurate diagnosis, and care management.
Each company is uniquely positioned to address a specific segment of the Japanese market. Toyaku Corporation is a progressive and rapidly growing healthcare company whose retail pharmacy chains provide an extensive array of prevention and lifestyle counseling services for patients. Saint-Care Corporation, a publicly traded firm, operates the third largest home- healthcare service in Japan. Millennia Corporation is a pioneer in medical data management and objective measurement of treatment efficacy. They will use MCC technologies to expand existing services into cognitive health with the aim of raising the standard of care in the dementia field.
As life expectancy increases in industrialized nations, the need to cope with Alzheimer’s disease and other diseases related to aging is urgent. Annual worldwide expenditures for the care of Alzheimer’s patients are approaching $500 billion and will rise sharply in coming years. While research into new Alzheimer’s treatments is essential, MCC enables health care providers to identify the disease at an earlier stage, use current treatments more effectively, and keep patients independent longer. Dennis Fortier, Medical Care Corporation’s President and CEO states: “The higher average life expectancy in Japan; coupled with a prevention oriented public healthcare system, make Japan an attractive market for Medical Care Corporation’s technology.” Mr. Fortier went on to explain that many patients can be helped immediately if healthcare providers have the tools to ensure early detection of a problem followed by an accurate diagnosis and proper treatment of any underlying medical conditions.
About Medical Care Corporation:
Medical Care Corporation (MCC) specializes in the development of medical technologies that enable healthcare providers to deliver improved levels of care in the field of dementia. MCC’s electronic Dementia Care System gathers, organizes, and synthesizes patient and treatment information so that healthcare providers are equipped to provide care at the highest possible level. Among MCC’s proprietary technologies, the Mental Skills Test is the most sensitive tool available for the detection of early stage memory loss. This highly sensitive test allows healthcare providers to identify and manage Alzheimer’s disease and related disorders at the earliest stages and use currently approved treatment modalities more effectively. The company is also a leader in communicating the value of prevention and early detection to patients and caregivers through its website and educational materials. Additional information about the company is available at two websites: Health care providers: http://www.mccare.com/; Patients and Caregivers: http://www.preventad.com/
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. William Rodman Shankle, M.D. http://profnet.prnewswire.com/ud_public.jsp?userid=505909
Medical Care Corporation
CONTACT: Medical Care Corporation, +1-949-838-0154; or Diane Daybreak,dday@teleport.com, for Medical Care Corporation